Loading...
Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
The combination of BRAF-targeted agents with immune checkpoint inhibitors represents a recent advance in the treatment of melanoma, even though each of these therapeutic approaches alone has specific limitations. Increasing evidence suggests indeed the existence of a synergistic interaction between...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3667913/ https://ncbi.nlm.nih.gov/pubmed/23762807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24320 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|